The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 05, 2020
Filed:
May. 31, 2019
Applicants:
College of William & Mary, Williamsburg, VA (US);
Auxulin Pharmaceuticals Inc, Chesterland, OH (US);
Inventors:
Thomas Ritz, Chesterland, OH (US);
Gary Ritz, Chesterland, OH (US);
Jason P. McDevitt, Williamsburg, VA (US);
Assignee:
Other;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 33/14 (2006.01); A61K 38/28 (2006.01); A61K 9/00 (2006.01); A61P 3/10 (2006.01); A61K 31/194 (2006.01); A61K 31/19 (2006.01); A61K 31/375 (2006.01);
U.S. Cl.
CPC ...
A61K 33/14 (2013.01); A61K 9/0053 (2013.01); A61K 9/0095 (2013.01); A61K 31/19 (2013.01); A61K 31/194 (2013.01); A61K 31/375 (2013.01); A61K 38/28 (2013.01); A61P 3/10 (2018.01);
Abstract
The disclosure describes methods and compositions for reducing the duration of hyperglycemia and treating diabetes and complications thereof. A human subject with hyperglycemia is administered insulin, a water-based beverage, and a sodium salt formulation sufficient to accelerate said subject's return to a non-hyperglycemic state. This process can be repeated multiple times within a given time period.